HTA is multi-disciplinary field of policy analysis that examines the medical, economic, social and ethical implications of the incremental value, diffusion and use of a health technology in health care.
The term Health Technology refers to application of organised knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of life.
Left ventricular assist devices help keep blood flowing through the body by assisting a specific chamber in the hearts of patients with severe heart failure. A left ventricular assist device can be implanted as a last resort for patients with severe heart failure who cannot have heart transplantation; this is called destination (permanent) therapy. Earlier devices used […]
Left ventricular assist device (LVAD) is considered an alternative to transplantationin end stage acute or chronic left ventricular congestive heart failure (HF). Use of LVAD improves the allocation of transplants alleviating the shortage of donors. The target population of the technology is represented by patients with end stage heart failure. Objectives: To assess the effect of using a […]
Cardiac transplantation is currently the preferred long-term treatment of eligible patients with end-stage advanced heart failure. The availability of donor hearts is limited and not all patients may tolerate cardiac transplantation. Implantable left ventricular assist devices (LVADs), that fully or partly support the left ventricle, are suggested as an alternative therapy for patients with end-stage advanced heart failure. In our report […]
The objective of this health technology policy assessment was to determine the effectiveness and cost-effectiveness of using implantable ventricular assist devices in the treatment of end-stage heart failure. Heart failure is a complex syndrome that impairs the ability of the heart to maintain adequate blood circulation, resulting in multiorgan abnormalities and, eventually, death. In the period of 1994 […]